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Abstract: Berberine originates from a
Chinese herbal medicine and possesses a wide
variety of anti-cancer activities. In this study,
the killing effect of berberine on
nasopharyngeal carcinoma cells (NPC/HK1)
was investigated. The trypan blue exclusion
assay was used to assess the cytotoxic effect
of berberine in this cell line. Berberine, at 5200 µM, induced cell death in a dosedependent manner. Treatment of cells with
200 µM berberine for 5 h yielded a lethal dose
of 50% (LD50). The Comet Assay was
employed to evaluate the extent of DNA
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Introduction
Traditional Chinese drugs have been used in China for
many years. However, they have not be merged into the
mainstream of Western medicine, even in the developed
cities in Southeast Asia. This is because there is not
sufficient scientific evidence of the therapeutic effects.
Recently, these therapeutics agents have been studied
systematically and are now being tried clinically in several
Western research centers (1-3).
Nasopharyngeal carcinoma (NPC) encompasses any
squamous cell carcinoma arising in the nasopharynx, a
tubular space situated at the base of the skull. This cancer
is relatively rare in Caucasian populations, but is prevalent
among the Southern Chinese, especially in Guangdong
and Guangxi Provinces (4-6). The primary form of
treatment of NPC is radiotherapy. The efficacy of this
treatment depends on the radiosensitivity of the tumor
and the ability to deliver an adequate radiation dosage to
all affected areas, while sparing normal tissues. Although
radiotherapy can eradicate the majority of the primary
tumor, recurrent or residue disease occurs in 13-31% of
patients. The combination of chemotherapy with
secondary dose radiotherapy was given for relapse

damage and repair after berberine treatment
(0 -100 µM). DNA damage was evident within
30 min and was more pronounced after 1.5
h. The damaged cells were not able to be
repaired, as indicated by the increase in tail
DNA content. However, the repair of H2O2
mediated DNA damage on this cell line
occurred within 1.5 h, indicating that DNA
repair inhibition may have contributed to the
high efficacy of cell killing by berberine.
Key Words: Cytotoxicity, DNA damage,
repair, cellular localization, berberine

patients. Nevertheless, all cytotoxic agents create adverse
reactions, including bone marrow suppression,
cardiotoxicity and renal damage, which justify more
effective therapeutic regimes (7-10).
Berberine is an alkaloid isolated from the root of
Coptis chinensis, a Chinese herbal plant (11). Numerous
pharmacological activities have been reported, e.g. antibacterial activity (12,13), including antimalarials (14),
and antileishmanial (15). The anti-tumor properties of
berberine are now becoming recognized by researchers
and clinical oncologists. The effects of berberine on
human malignant brain tumor, esophageal cancer, and
human leukemic and human colon cancer cell lines were
tested; a significant killing effect was achieved (16-19). In
this study, we investigated the cytotoxicity and the DNA
damage effect on NPC/HK1 cells after berberine
treatment and evaluated the possibility of DNA repair in
this cell line. To further understand the biological action
of berberine, we also examined the relationship between
drug uptake and cellular localization. Finally, the
molecular mechanisms of berberine on NPC/HK1 cell
death were explored.
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Materials and Methods
Chemicals
Berberine
chloride,
DAPI
(4,6-diamidine2,phenylindole dihydrochloride) stain, D-mannitol, and
catalase were purchased from Sigma, St. Louis, MO, USA.
The stock solution of berberine was prepared by
dissolving the berberine powder in phosphate-buffered
saline (PBS). A further dilution with PBS was made of this
solution as required just before testing. Trolox was
purchased from Aldrich, Dorset, UK.
Cell line and culture conditions
The NPC/HK1 cell line used in this study is a welldifferentiated squamous cell carcinoma originally derived
from a Chinese male patient (20). The cells were
routinely cultured in RPMI-1640 medium supplemented
with 10% fetal bovine serum (FBS, Gibco) and antibiotic
PSN (50 IU/mL penicillin, 50 µg/mL streptomycin and
100 µg/mL neomycin)(Gibco) at 37 °C in a humidified 5%
CO2 incubator.
Cell viability determination
The cell viability was evaluated by a trypan blue
exclusion assay. The NPC/HK1 cells were trypsinized with
0.25% trypsin. The cells was washed with PBS and then
resuspended in PBS. Ten microliters of cells were
transferred to microcentrifuge tubes with 1 ml of
different concentrations of berberine (0-200 µM) for
various treatment times (ranging from 1 to 5 h) at 37 °C.
After incubation, the treated and untreated cells were
washed with PBS and mixed with equal volumes of 0.2%
of trypan blue solution. The cells were examined in a
counting chamber with a light microscope. Viable and
non-viable cells were recorded. Each assay was done in
triplicate. The results were expressed as mean ± SD of
more than three independent experiments.
Alkaline Comet Assay
The effect of berberine on cellular DNA was evaluated
by the comet assay. The cells were incubated in different
concentrations (0-200 µM) of berberine at 37 °C for 1 h.
After incubation, the treated cells were washed with PBS
and the cells were then mixed with 85 µl of 1% low
melting point agarose gel (Type VII, Sigma) in the
microcentrifuge tube. The mixture was applied to a
microscope slide precoated with 85 µl of 1% standard
agarose (Sigma) in PBS. Cell membrane was lysed with a
cold lysis solution (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris,
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pH 10, 1% Triton X-100). Lysis was performed by
submerging the slides in a staining jar in the absence of
light for 1 h at 4 °C. Subsequently, slides were
transferred to an electrophoresis tank containing 0.3 M
NaOH and 1 mM EDTA (4 °C) for 40 min to allow for
DNA unwinding and expression of alkali-labile sites.
Electrophoresis was performed for 30 min at 25 V (0.83
V/cm). The current was maintained at 0.3 A by adjusting
the electrophoresis solution level. After electrophoresis,
slides were neutralized by three changes (3 x 5 min) of
0.4 M Tris with pH 7.5. Slides were dried and stained
with 20 µg/mL ethidium bromide for image analysis (23).
The results were expressed as mean ± SD of more than
three independent experiments. The changes in tail DNA
content were statistically evaluated using Dunnett’s t-test.
Effect of antioxidants on berberine induced
cytotoxicity and DNA damage
Two antioxidants and one antioxidant enzyme, namely
D-mannitol, Trolox and catalase, were used to explore the
molecular mechanism of berberine on NPC/HK1. The cells
were co-incubated with various concentrations of
berberine (0-200 µM) and a fixed concentration of
antioxidant (200 µM D-mannitol, or 200 µM Trolox, or
233 IU per ml catalase) at 37 °C. The trypan blue and
comet assay were performed 1 h after incubation. The
results were expressed as mean ± SD of three
independent experiments.
Effect of berberine on DNA repair capacity
The DNA repair capacity of NPC cells after berberine
treatment was determined by the comet assay. The DNA
damage of the cells, with or without a 1.5 h recovery
period, was measured and compared. The DNA damage,
mediated by hydrogen peroxide, was used as a positive
control of repair ability. The NPC cells were incubated
with various concentrations with either 1 ml berberine
solution (25, 50 and 100 µM) at 37 °C for 30 min or 1
ml of H2O2 (50, 75 and 100 µM) at 4 °C for 5 min. After
incubation, the mixture was centrifuged and the
supernatant was removed. The cell pellets were mixed
with low melting point agarose gel for the comet assay.
The control for the recovery period using 1.0 ml of RPMI
with 10% FBS was added and the cells were incubated
for an additional 1.5 h at 37 °C. At the end of the
recovery period, the cells were centrifuged, washed with
PBS twice, and mixed with the low melting point agarose
gel for the comet assay measurement. The results were

S. SZETO, C. M. N. YOW, K. W. FUNG

Apoptosis was evaluted by the DAPI (4,6-diamidine2,phenylindole dihydrochloride) nuclear staining method
(22). Berberine was dissolved in the culture medium
(RPMI 1640 with 10% fetal calf serum). The cells were
treated in 100 and 200 µM of berberine from 2 h to 24
h. The cells were then washed in PBS and fixed with 4%
paraformadehyde in PBS for 15 min. The cells were
washed again and stained with 1 ml of 1% DAPI stain at
37 °C for 15 min. The nuclear regions of the cells were
examined by fluorescent microscope using a 330-380 nm
excitation and a 420 nm emission filter. Apoptotic nuclei
showed the standard characteristics of a condensed
chromatin pattern. The cells were identified, and the
percentage of apoptotic cells was determined by counting
100 cells per field for more than 10 fields; two individual
experiments were performed (22-24).
Cellular localization of berberine
The berberine uptake and localization in NPC cells
were determined by employing its own fluorescent
properties (14). Berberine, dissolved in the culture
medium (with final concentration of 200 and 400 µM),
was incubated with the cells for 2 to 46 h. Afterwards,
the cells were washed twice in PBS, followed by
examination under a fluorescent microscope (excitation
420 nm; emission 520 nm).

Vibality (%) (mean, n = 3)

Detection of cell morphological changes by the
DAPI nuclear stain

2 hour
90

The cytotoxic activity was expressed in percentage of
cell viability. The duration of the treatment was 1 to 5 h.
The results showed that the cytotoxic effect was
positively related to berberine concentration (Figure 1).
After 1 h incubation, the cell viability was generally
decreased, while the concentration of berberine
increased. At a berberine concentration of 5 µM, cell
viability was reduced to 15% (after 1 h treatment) when
compared to the untreated cell. At 200 µM of berberine,
cell viability dropped to 60%.
Berberine-induced DNA damage
After 30 min of berberine treatment (5–200 µM),
DNA damage was evidenced in the comet assay. The mean
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Figure 1.
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Viability of NPC/HK1 cells after berberine treatment. Cells
were incubated in different concentrations (5-200 µM) of
berberine for 1 to 5 h. Each data point represents the mean
of three individual experiments.

tail DNA content increased as berberine concentration
increased (Figure 2). However, the results indicated that
a statistically significant increase in DNA damage was
observed only at 200 µM (Dunnett’s t-test, p < 0.01).
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Results
Cytotoxicity of berberine on NPC/HK1 cell
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100
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expressed as mean ± SD of more than three independent
experiments.

0
0

50

100

150

200

250

Berberine concentration (µM)
Figure 2.

DNA damage of NPC/HK1 cells after 30 min treatment of
berberine at different concentrations (5-200 µM). DNA
damage was expressed in percentage of DNA content in the
comet tails. The results are mean ± 1 SD of three individual
experiments.

Effect of antioxidants on berberine-induced
cytotoxicity and DNA damage
The cell viability and DNA damage of NPC/HK1 cells,
after berberine treatment with or without co-incubation
of antioxidants, was compared. The results showed that
co-incubation of berberine with D-mannitol at 200 µM
was unable to increase the cell viability or reduce DNA
damage (unpaired t-test, p > 0.05, data not shown).
Furthermore, no protection but adverse effects of Trolox
treatment was observed on DNA damage (unpaired t-test,
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100
berberine only

Berberine treated without 1.5 h repair
period

100

Berberine treated and with 1.5 h
repair period

75

Tail DNA content (%)

Tail DNA content (%) (mean ± 1SD, n=3)

p < 0.05) (Figure 3). In contrast, for the co-incubation of
berberine and catalase, cell viability was increased when
compared to those incubated with berberine alone
(unpaired t-test, p < 0.05) (Figure 4). This indicated that
the berberine-induced cell death may be partly mediated
by hydrogen peroxide.
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H 2 O 2 treated without 1.5 h repair
period
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1.5 h repair period

DNA damage of NPC/HK1 cells after 1 h treatment of
berberine at different concentrations (5-200 µM) with or
without co-incubation with Trolox. A statistically significant
increase in tail DNA content was found with the presence
of Trolox (Unpaired t-test, * = p < 0.05).
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Figure 5.
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Figure 4.

*

Berberine only

50

DNA damage of NPC/HK1 cells immediately after treatment
or with 1.5 h of recovery period. a) NPC/HK1 cells treated
with 25, 50 and 100 µM berberine for 30 min at 37 °C. b)
NPC/HK1 cells treated with 50, 75 and 100 µM hydrogen
peroxide for 5 min at 4 °C. Results are mean ± 1 SD of
three individual experiments.

250

Viability of NPC/HK1 cells after 1 h treatment of berberine
at different concentrations (5-200 µM) with or without coincubation with catalase. A statistically significant increase
in viability was found with the presence of catalase
(Unpaired t-test, * = p < 0.05, *** = p < 0.001).

Effect of berberine on DNA repairing capacity
These results showed that NPC/HK1 cells were not
able to repair the damaged DNA after berberine
treatment. The tail DNA content was increased further
after 1.5 h, when compared with that of the matched
concentration, without allowing the cells to recover
(Figure 5a).
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Tail DNA content (%)

Berberine concentration (µM)
Figure 3.

H 2 O 2 treated and with

250

H2O2 treatment was used as a positive control of DNA
repair ability. NPC/HK1 cells were able to repair H2O2
mediated DNA damage. The results showed a statistically
significant decrease in DNA damage after the 1.5 h
recovery period at 75 and 100 µM (Figure 5b).
Apoptosis by DAPI
No apoptotic cells were observed at 100 µM and 200
µM berberine treatment from 2 to 19 h of incubation.
Only a few apoptotic cells were present after 24 h with
200 µM berberine treatment (200 µM); this was nonsignificant.
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Drug uptake, and intracellular localization of
berberine
Berberine was observed mainly in the cytoplasmic
region at 2 h of incubation at 200 µM. At higher
concentrations and longer incubation times (200 µM, 8
h), berberine was observed near the nuclear regions of
the cells (Figures 6).

Discussion
In this study, the cancer cell killing effect was assessed
and an effective cytotoxicity (LD50) was achieved within a
reasonable length of treatment (5 h) and concentration
(200 µM). In addition to cell killing, DNA was found to be
damaged after treatment. It was indicated that berberine
toxicity on NPC/HK1 cells may be partly mediated
through hydrogen peroxide (Figure 4), because catalase
alleviated the adverse effect on the DNA and the viability
of NPC cells contributed by berberine. The DNA damage
caused by hydrogen peroxide was repaired (Figure 5b).
Therefore, inhibition of DNA repair activity did not occur
via the presence of hydrogen peroxide. Furthermore,
berberine was observed to be near the nuclear region. It
has been noted that berberine was able to bind with DNA
(18) and may inhibit DNA topoisomerase II. Therefore,
inhibition of DNA repair ability and stability may also
contribute to the cytotoxic effect on the NPC cells.
However, no significant amount of apoptotic cells was
triggered in the cells after berberine treatment, even
though this has been observed in other cell lines (18,25).
This may be due to the different thresholds of drug
treatment that are required in order to see a biological
effect.

(a)

(b)

A large variation in tail DNA content was observed in
the comet assay data. Since the comet assay is a highly
sensitive tool for DNA damage detection, a large amount
of damaged DNA may lead to difficulty in defining the
comet head and tail and hence give variations in tail DNA
content among individual experiments.

(c)
Figure 6.

NPC/HK1 cells cultured on culture dish were incubated
with 200 µM of berberine for 2-46 h. a) Cells treated for 2
h; b) Cells treated for 21 h; c) Cells treated for 46 h.
Fluorescence indicates the presence of berberine.

In conclusion, berberine treatment on NPC cells
demonstrated a high killing efficacy. The DNA damaging
effect and the inhibition of DNA repair contributed to the
cytotoxic activity in the cancer cells; this may be part of
the mechanisms of action of berberine on cancer cells.
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